A Randomized Controlled Study of Moxibustion in the Treatment of Shoulder-Hand Syndrome after Ischemic Stroke
- Conditions
- post-stroke shoulder-hand syndrome
- Registration Number
- ITMCTR2100005261
- Lead Sponsor
- The First Affiliated Hospital of He'nan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the diagnostic criteria for stroke (including ischemic and hemorrhagic stroke) by computed tomography (CT) or magnetic resonance imaging (MRI);
2. Aged 18 to 75 years, the course of the disease does not exceed 12 months;
3. All vital signs after stroke are stable, meet the diagnostic criteria for shoulder-hand syndrome, and belong to stage I or II according to the staging criteria;
4. Those who have a clear consciousness and can perform and tolerate fine moxibustion treatment.
1. Patients with other serious diseases that may affect the results of treatment and threaten life, such as heart disease, liver disease, lung disease, kidney disease, diabetes, osteoporosis or bleeding tendency;
2. Patients who are pregnant, breastfeeding or planning to become pregnant;
3. Patients with severe cognitive impairment who cannot cooperate with treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Fugl–Meyer Assessment for upper Extremity;Assessment of hand swelling;visual analogue scale ;
- Secondary Outcome Measures
Name Time Method Surface Electromyography ;range of motion;Te Modified Barthel Index Score;